Cargando…

Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study

BACKGROUND: We examined trends in AIDS-defining illnesses (ADIs) among individuals receiving highly active antiretroviral therapy (HAART) in British Columbia (BC), Canada to determine whether declines in ADIs could be contributing to previously observed improvements in life-expectancy among HAART pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jafari, Siavash, Chan, Keith, Aboulhosn, Kewan, Yip, Benita, Lima, Viviane D, Hogg, Robert S, Montaner, Julio, Moore, David M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180248/ https://www.ncbi.nlm.nih.gov/pubmed/21892955 http://dx.doi.org/10.1186/1742-6405-8-31

Ejemplares similares

Physician's manual reporting underestimates mortality: evidence from a population-based HIV/AIDS treatment program
por: Au-Yeung, Christopher G, et al.
Publicado: (2010)

Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function
por: Guillemi, Silvia A, et al.
Publicado: (2016)

Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy
por: Lima, Viviane D., et al.
Publicado: (2012)

Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada
por: Nosyk, Bohdan, et al.
Publicado: (2013)

Physicians’ patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting
por: Allan, Beverly, et al.
Publicado: (2019)

Adi Armoni
por: Armoni, Adi
Publicado: (2022)

Adie's Syndrome
por: Marmion, Vincent
Publicado: (1975)

Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100
por: Alleva, David G., et al.
Publicado: (2020)

Disparities in the Burden of HIV/AIDS in Canada
por: Hogg, Robert S., et al.
Publicado: (2012)

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
por: Lima, Viviane D, et al.
Publicado: (2006)

Correction: Disparities in the Burden of HIV/AIDS in Canada
por: Hogg, Robert S., et al.
Publicado: (2018)

The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada
por: Lima, Viviane Dias, et al.
Publicado: (2015)

The ADI model problem
por: Wachspress, Eugene
Publicado: (2013)

Adie’s Tonic Pupil
por: Kanzaria, Hemal K, et al.
Publicado: (2012)

Pupila de Adie
por: Babiano Fernandez, Miguel Angel
Publicado: (2020)

Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
por: Montaner, Julio S.G., et al.
Publicado: (2014)

Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2010)

Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART
por: Hogg, Robert S, et al.
Publicado: (2006)

HIV/AIDS in Vancouver, British Columbia: a growing epidemic
por: McInnes, Colin W, et al.
Publicado: (2009)

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
por: Harris, Marianne, et al.
Publicado: (2012)

Gender Inequities in Quality of Care among HIV-Positive Individuals Initiating Antiretroviral Treatment in British Columbia, Canada (2000–2010)
por: Carter, Allison, et al.
Publicado: (2014)

Relationship between Food Insecurity and Mortality among HIV-Positive Injection Drug Users Receiving Antiretroviral Therapy in British Columbia, Canada
por: Anema, Aranka, et al.
Publicado: (2013)

326. Is Antiretroviral Treatment Averting AIDS and non-AIDS Defining Malignancies in Colombia?
por: Martínez Buitrago, Ernesto, et al.
Publicado: (2019)

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
por: Zhu, Jielin, et al.
Publicado: (2019)

Adie’s Pupil: A Diagnostic Challenge for the Physician
por: Xu, Sui-yi, et al.
Publicado: (2022)

Risk of Deaths, AIDS-Defining and Non-AIDS Defining Events among Ghanaians on Long-Term Combination Antiretroviral Therapy
por: Sarfo, Fred Stephen, et al.
Publicado: (2014)

Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation
por: Pettit, April C, et al.
Publicado: (2018)

Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay
por: Brumme, Chanson J., et al.
Publicado: (2012)

Rates of inappropriate antiretroviral prescription among injection drug users
por: Wood, Evan, et al.
Publicado: (2007)

An interesting case of simultaneous bilateral Adie's tonic pupil
por: Saha, Indranil, et al.
Publicado: (2018)

Dilute pilocarpine test for diagnosis of Adie’s tonic pupil
por: Yoo, Yung-Ju, et al.
Publicado: (2021)

Early Dorsal Midbrain Syndrome Mimicking an Adie's Tonic Pupil
por: Han, Sang Won, et al.
Publicado: (2010)

Adie's Tonic Pupil in Systemic Sclerosis: A Rare Association
por: Venkataraman, Anusha, et al.
Publicado: (2015)

A Rare Case in the Emergency Department: Holmes-Adie Syndrome
por: COLAK, Sahin, et al.
Publicado: (2016)

This special volume of mesothelioma is dedicated to my friend Adi Gazdar
por: Carbone, Michele
Publicado: (2020)

Pupila tónica de Adie y otros signos asociados
por: Rendón Fernández, Helena, et al.
Publicado: (2021)

The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study
por: Ma, Huiting, et al.
Publicado: (2018)

Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare
por: Tapp, Christine, et al.
Publicado: (2011)

Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings
por: Lima, Viviane D, et al.
Publicado: (2016)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
por: Antoniou, Tony, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u1o4nr898vdp5lgrs93cn9fr43